Published in Dev Psychopathol on January 01, 2007
Modifying resilience mechanisms in at-risk individuals: a controlled study of mindfulness training in Marines preparing for deployment. Am J Psychiatry (2014) 2.12
Personality, adrenal steroid hormones, and resilience in maltreated children: a multilevel perspective. Dev Psychopathol (2007) 1.48
Identifying key features of early stressful experiences that produce stress vulnerability and resilience in primates. Neurosci Biobehav Rev (2010) 1.30
The presence of resilience is associated with a healthier psychological profile in intensive care unit (ICU) nurses: results of a national survey. Int J Nurs Stud (2011) 1.21
Posttraumatic stress disorder following the September 11, 2001, terrorist attacks: a review of the literature among highly exposed populations. Am Psychol (2011) 1.16
Reconsidering the placebo response from a broad anthropological perspective. Cult Med Psychiatry (2009) 1.05
Conceptualizing and re-evaluating resilience across levels of risk, time, and domains of competence. Clin Child Fam Psychol Rev (2008) 0.97
Stress-induced visceral pain: toward animal models of irritable-bowel syndrome and associated comorbidities. Front Psychiatry (2015) 0.96
Infants' meaning-making and the development of mental health problems. Am Psychol (2011) 0.95
Assessment of a prevention program for work-related stress among urban police officers. Int Arch Occup Environ Health (2012) 0.92
Finding behavioral and network indicators of brain vulnerability. Front Hum Neurosci (2012) 0.91
Stress resilience in male adolescents and subsequent stroke risk: cohort study. J Neurol Neurosurg Psychiatry (2014) 0.91
Reconceptualizing schizophrenia. Schizophr Bull (2013) 0.90
Concepts of scientific integrative medicine applied to the physiology and pathophysiology of catecholamine systems. Compr Physiol (2013) 0.88
Adolescents' cortisol reactivity and subjective distress in response to family conflict: the moderating role of internalizing symptoms. J Adolesc Health (2011) 0.87
DRD4-exonIII-VNTR moderates the effect of childhood adversities on emotional resilience in young-adults. PLoS One (2011) 0.85
Pharmacotherapy in post-traumatic stress disorder: evidence from randomized controlled trials. Curr Opin Investig Drugs (2009) 0.84
Mesolimbic dopamine D₂ receptor plasticity contributes to stress resilience in rats subjected to chronic mild stress. Psychopharmacology (Berl) (2013) 0.84
Association of DHEA, DHEAS, and cortisol with childhood trauma exposure and post-traumatic stress disorder. Int Clin Psychopharmacol (2014) 0.80
Resilience: A psychobiological construct for psychiatric disorders. Indian J Psychiatry (2016) 0.76
Psychological and social resources relate to biomarkers of allostasis in newly admitted nursing home residents. Aging Ment Health (2015) 0.75
Differential Effects of Controllable Stress Exposure on Subsequent Extinction Learning in Adult Rats. Front Behav Neurosci (2016) 0.75
The Impact of Hope and Resilience on Multiple Factors in Neurosurgical Patients. Cureus (2016) 0.75
Examining self-reported and biological stress and near misses among Emergency Medicine residents: a single-centre cross-sectional assessment in the USA. BMJ Open (2017) 0.75
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum (1988) 111.05
The development of a Clinician-Administered PTSD Scale. J Trauma Stress (1995) 22.71
The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry (1989) 16.61
Antidepressant effects of ketamine in depressed patients. Biol Psychiatry (2000) 10.91
Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry (1994) 8.88
The Yale-Brown Obsessive Compulsive Scale. II. Validity. Arch Gen Psychiatry (1989) 6.80
MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder. Am J Psychiatry (1995) 5.34
Consistency of memory for combat-related traumatic events in veterans of Operation Desert Storm. Am J Psychiatry (1997) 5.13
Hippocampal volume reduction in major depression. Am J Psychiatry (2000) 5.04
Substance use disorders in patients with posttraumatic stress disorder: a review of the literature. Am J Psychiatry (2001) 3.69
Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry (1990) 3.57
Magnetic resonance imaging-based measurement of hippocampal volume in posttraumatic stress disorder related to childhood physical and sexual abuse--a preliminary report. Biol Psychiatry (1997) 3.39
Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci U S A (1996) 3.28
The cellular neurobiology of depression. Nat Med (2001) 3.19
Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS). J Trauma Stress (1998) 3.07
Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Mol Psychiatry (2002) 3.01
Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists. Arch Gen Psychiatry (2000) 2.92
Abnormal noradrenergic function in posttraumatic stress disorder. Arch Gen Psychiatry (1993) 2.89
Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch Gen Psychiatry (1999) 2.78
Neural correlates of exposure to traumatic pictures and sound in Vietnam combat veterans with and without posttraumatic stress disorder: a positron emission tomography study. Biol Psychiatry (1999) 2.62
Low urinary cortisol excretion in Holocaust survivors with posttraumatic stress disorder. Am J Psychiatry (1995) 2.39
Neural correlates of memories of childhood sexual abuse in women with and without posttraumatic stress disorder. Am J Psychiatry (1999) 2.35
Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. Am J Psychiatry (1998) 2.30
Effects of early adverse experiences on brain structure and function: clinical implications. Biol Psychiatry (2000) 2.27
Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder. Am J Psychiatry (1997) 2.22
Clinical phenomenology and neurobiology of cocaine abstinence: a prospective inpatient study. Am J Psychiatry (1991) 2.17
Childhood physical abuse and combat-related posttraumatic stress disorder in Vietnam veterans. Am J Psychiatry (1993) 2.16
Neuroendocrine and behavioral responses to intravenous m-chlorophenylpiperazine (mCPP) in depressed patients and healthy comparison subjects. Am J Psychiatry (1994) 2.04
Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography. Biol Psychiatry (1998) 2.03
Dose-related ethanol-like effects of the NMDA antagonist, ketamine, in recently detoxified alcoholics. Arch Gen Psychiatry (1998) 2.02
Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder. Biol Psychiatry (1999) 1.97
Noradrenergic mechanisms in stress and anxiety: I. Preclinical studies. Synapse (1996) 1.97
Psychobiologic mechanisms of posttraumatic stress disorder. Arch Gen Psychiatry (1993) 1.88
Chronic PTSD in Vietnam combat veterans: course of illness and substance abuse. Am J Psychiatry (1996) 1.87
Deficits in short-term memory in posttraumatic stress disorder. Am J Psychiatry (1993) 1.81
Age-related decline in striatal dopamine transporter binding with iodine-123-beta-CITSPECT. J Nucl Med (1995) 1.77
Noradrenergic mechanisms in stress and anxiety: II. Clinical studies. Synapse (1996) 1.75
Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease. Ann Neurol (1995) 1.70
Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo. Arch Gen Psychiatry (1989) 1.66
Low urinary cortisol excretion in patients with posttraumatic stress disorder. J Nerv Ment Dis (1990) 1.63
Effects of experimental context and explicit threat cues on acoustic startle in Vietnam veterans with posttraumatic stress disorder. Biol Psychiatry (1998) 1.62
Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: a double-blind, placebo-controlled trial. Am J Psychiatry (1997) 1.59
Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine. Arch Gen Psychiatry (1990) 1.56
Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder. Am J Psychiatry (1993) 1.56
SPECT imaging of striatal dopamine release after amphetamine challenge. J Nucl Med (1995) 1.56
Hereditary factors in sleepwalking and night terrors. Br J Psychiatry (1980) 1.54
Hypothalamic-pituitary-adrenal dysfunction in posttraumatic stress disorder. Biol Psychiatry (1991) 1.52
Dissociation and posttraumatic stress disorder in Vietnam combat veterans. Am J Psychiatry (1992) 1.52
Imaging D2 receptor occupancy by endogenous dopamine in humans. Neuropsychopharmacology (1997) 1.50
Lithium treatment and serotoninergic function. Neuroendocrine and behavioral responses to intravenous tryptophan in affective disorder. Arch Gen Psychiatry (1989) 1.49
Plasma neuropeptide-Y concentrations in humans exposed to military survival training. Biol Psychiatry (2000) 1.49
Clinical and medication outcome after short-term alprazolam and behavioral group treatment in panic disorder. 2.5 year naturalistic follow-up study. Arch Gen Psychiatry (1989) 1.47
A controlled trial of lithium augmentation in fluvoxamine-refractory obsessive-compulsive disorder: lack of efficacy. J Clin Psychopharmacol (1991) 1.45
Baseline startle amplitude and prepulse inhibition in Vietnam veterans with posttraumatic stress disorder. Psychiatry Res (1996) 1.43
Reductions in occipital cortex GABA levels in panic disorder detected with 1h-magnetic resonance spectroscopy. Arch Gen Psychiatry (2001) 1.43
The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans. Pharmacopsychiatry (1996) 1.43
Serotonin function and depression: neuroendocrine and mood responses to intravenous L-tryptophan in depressed patients and healthy comparison subjects. Am J Psychiatry (1991) 1.43
Dissociation in aging Holocaust survivors. Am J Psychiatry (1996) 1.42
Cortisol response to a cognitive stress challenge in posttraumatic stress disorder (PTSD) related to childhood abuse. Psychoneuroendocrinology (2003) 1.41
Rapid detoxification from opioid dependence. Am J Psychiatry (1989) 1.40
Fear-potentiated startle in posttraumatic stress disorder. Biol Psychiatry (1995) 1.38
Pathologic analysis of advanced adult soft tissue sarcomas, bone sarcomas, and mesotheliomas. The Eastern Cooperative Oncology Group (ECOG) experience. Cancer (1989) 1.38
A randomized clinical trial of repetitive transcranial magnetic stimulation in the treatment of major depression. Biol Psychiatry (2000) 1.37
Diagnostic specificity of synovial lesions. Hum Pathol (1981) 1.36
Dissociation of ketamine effects on rule acquisition and rule implementation: possible relevance to NMDA receptor contributions to executive cognitive functions. Biol Psychiatry (2000) 1.33
Yohimbine induced anxiety and increased noradrenergic function in humans: effects of diazepam and clonidine. Life Sci (1983) 1.32
Positron emission tomography measurement of cerebral metabolic correlates of yohimbine administration in combat-related posttraumatic stress disorder. Arch Gen Psychiatry (1997) 1.31
Effect of darkness on acoustic startle in Vietnam veterans with PTSD. Am J Psychiatry (1998) 1.30
Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder. Arch Gen Psychiatry (1984) 1.28
The psychobiological basis of posttraumatic stress disorder. Mol Psychiatry (1996) 1.28
Deficits in short-term memory in adult survivors of childhood abuse. Psychiatry Res (1995) 1.27
Symptoms of dissociation in humans experiencing acute, uncontrollable stress: a prospective investigation. Am J Psychiatry (2001) 1.26
NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders. Harv Rev Psychiatry (1999) 1.26
Transcranial magnetic stimulation of left temporoparietal cortex in three patients reporting hallucinated "voices". Biol Psychiatry (1999) 1.25
Preliminary evidence of low cortical GABA levels in localized 1H-MR spectra of alcohol-dependent and hepatic encephalopathy patients. Am J Psychiatry (1999) 1.25
Investigation of the effect of growth environment on the stability of low-copy-number plasmids in Escherichia coli. J Gen Microbiol (1987) 1.24
[123I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease. Neurology (1996) 1.24
Perceived abuse and neglect as risk factors for suicidal behavior in adolescent inpatients. J Nerv Ment Dis (1999) 1.23
Microdialysis and SPECT measurements of amphetamine-induced dopamine release in nonhuman primates. Synapse (1997) 1.23
Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients. J Nucl Med (1998) 1.22
Clinical and functional correlates of posttraumatic stress disorder in urban adolescent girls at a primary care clinic. J Am Acad Child Adolesc Psychiatry (2000) 1.22
Graphical, kinetic, and equilibrium analyses of in vivo [123I] beta-CIT binding to dopamine transporters in healthy human subjects. J Cereb Blood Flow Metab (1994) 1.21
Startle gating deficits occur across prepulse intensities in schizophrenic patients. Biol Psychiatry (1992) 1.21